EMTRAIN is establishing a sustainable, pan-European platform for education and training covering the whole life-cycle of medicines research.
This is achieved by integrating the strengths and competencies of the ESFRI-BMS Infrastructures (European Strategy Forum on Research Infrastructures – Biological and Medical Sciences), the EFPIA companies (European Federation of Pharmaceutical Industries and Association), the current and future IMI E&T programmes and other scientific projects.
EMTRAIN focuses on three key initiatives:
- on-course®: www.on-course.eu is the most comprehensive and sustainable biomedical and medicines research and development postgraduate course portal in Europe. It offers fast and free access to all the important course information summarised in a single page for students, professionals and scientists to find the right high-quality courses.
- PPP PhD programme: EMTRAIN seeks to develop a cadre of PhD students across the EU with a greater awareness of the pharmaceutical industry and of its specific issues and challenges that need to be addressed.
- LifeTrain: A broad group of European professional and scientific bodies and the IMI E&T projects have together started to develop “LifeTrain”, a common European Framework for Continuous Professional Development, led by EMTRAIN. This guidance will support scientists working in all aspects of medicines’ discovery, development, processing and usage to maintain their professional competence in a rapidly changing environment.
Researchers of the Medical University
The Medical University of Vienna is project coordinator under the leadership of Univ.-Prof. Dr. Michael Wolzt, Universitätsklinik für Klinische Pharmakologie.
Project staff (Univ. clinic for clinical pharmacology in the EMTRAIN Project Office):
Mag.a Christa Janko
MA, Dr. Pavel Dallakian
Project coordinator: Univ.-Prof. Dr. Michael Wolzt, University clininic for clinical pharmacology, MedUni Vienna
Project partners: 26
|Topic||Innovative Medicines Initiative Joint Undertaking, Education & Training Pillar (1st IMI call 2008)|
|Project duration||01.10.2009 - 30.09.2016|
|Funding volume, total||7.535.143,33 € (4.000.000 € IMI-Finanzierung / 3.535.143,33 € EFPIA „in-kind contribution“)|
|Funding volume, Medical University of Vienna||1.468.400 €|